Global migraine drugs market was valued at USD 1,745 million in 2017. The market is projected to grow at a CAGR of 18.0% over the forecast period, culminating in global sales of USD 7,766 million in 2025. Migraine drugs market has been segmented by treatment type into acute/ abortive treatment and preventive/ prophylactic treatment. Approval of novel product candidates with differentiated profile for both acute and prevention of migraine are expected to drive the growth of the global migraine market.

CHAPTER 01 Report Scope 

CHAPTER 02 Methodology 

CHAPTER 03 Executive Summary 

CHAPTER 04 Disease Primer and Epidemiology

CHAPTER 05 Global Migraine Drugs Market Overview

CHAPTER 06 Migraine Drugs Market: Pipeline Intelligence

CHAPTER 07 Company Profiles

CHAPTER 08 Market Outlook